Gimv - News

16/02/2016 - 17:45

Hilde Laga succeeds Urbain Vandeurzen as chairwoman - Board of Directors Gimv confirms the succession of Urbain Vandeurzen by Hilde Laga at the financial year end (31 March 2016)

24/01/2016 - 18:05

Gimv announces the succession of Urbain Vandeurzen as Chairman of its Board of Directors

08/01/2016 - 07:30 Portfolio

Gimv acquires a majority stake in the newly merged group Itho Daalderop and Klimaatgarant

06/01/2016 - 17:45 Portfolio

Gimv invests in further growth of ironmongery distributor Legallais

18/12/2015 - 14:30 Portfolio

Gimv invests in the international growth of natural climate control and fire safety specialist Brakel

16/12/2015 - 07:30 Portfolio

Dental care in Flanders faced with huge challenges - Benedenti aims to expand the multidisciplinary group practice model throughout Flanders

20/11/2015 - 11:00 Portfolio

Bencis and Gimv-XL reach agreement on the sale of Xeikon

19/11/2015 - 07:00 Financial

Growing earnings at portfolio companies provides major contribution to strong half-year result of EUR 64.9 million - Net asset value up 5.9% on six months to EUR 43.09 per share

30/10/2015 - 07:30 Portfolio

Gimv backs further growth of Equipe Zorgbedrijven

09/09/2015 - 07:30 Portfolio

Biom’Up secures EUR 31,3 million in Series C financing from Bpifrance Large Venture, Gimv and Lundbeckfond Ventures

07/08/2015 - 17:00 Portfolio

Gimv’s medtech portfolio company JenaValve raises USD 26.5 million

06/08/2015 - 07:30 Portfolio

Belgian Web Performance Company CoScale Raises € 2 million from Gimv, Qbic and SOFI (PMV)

24/07/2015 - 07:00 Portfolio

Gimv's participation Almaviva Santé gets a new dimension thanks to the merger with Clinique Arago and the private hospital group Domus Cliniques

16/07/2015 - 07:00 Financial

Business update - First 3 months of the 2015/2016 financial year

24/06/2015 - 17:45 Financial

Report of the Ordinary General Shareholders’ Meeting - General Meeting approves gross dividend of EUR 2.45 per share

09/06/2015 - 17:45 Portfolio

Gimv sells stake in Easyvoyage

21/05/2015 - 07:00 Financial

Successful investment pathways leading to excellent annual result of EUR 136.0 million - Net asset value up 14% to EUR 42.97 per share - Stable gross dividend of EUR 2.45, representing a dividend yield of 5.8%

15/05/2015 - 08:18 Portfolio

Gimv portfolio company Prosonix to be acquired by Circassia Pharmaceuticals

07/05/2015 - 07:30 Portfolio

Gimv and the other shareholders are selling their stake in Acertys Groep, a major supplier to hospitals and medical professions

06/05/2015 - 17:45 Portfolio

Filter news:

Hilde Laga succeeds Urbain Vandeurzen as chairwoman - Board of Directors Gimv confirms the succession of Urbain Vandeurzen by Hilde Laga at the financial year end (31 March 2016)

Gimv announces the succession of Urbain Vandeurzen as Chairman of its Board of Directors

Gimv acquires a majority stake in the newly merged group Itho Daalderop and Klimaatgarant

Gimv invests in further growth of ironmongery distributor Legallais

Gimv invests in the international growth of natural climate control and fire safety specialist Brakel

Dental care in Flanders faced with huge challenges - Benedenti aims to expand the multidisciplinary group practice model throughout Flanders

Bencis and Gimv-XL reach agreement on the sale of Xeikon

Growing earnings at portfolio companies provides major contribution to strong half-year result of EUR 64.9 million - Net asset value up 5.9% on six months to EUR 43.09 per share

Gimv backs further growth of Equipe Zorgbedrijven

Biom’Up secures EUR 31,3 million in Series C financing from Bpifrance Large Venture, Gimv and Lundbeckfond Ventures

Gimv’s medtech portfolio company JenaValve raises USD 26.5 million

Belgian Web Performance Company CoScale Raises € 2 million from Gimv, Qbic and SOFI (PMV)

Gimv's participation Almaviva Santé gets a new dimension thanks to the merger with Clinique Arago and the private hospital group Domus Cliniques

Business update - First 3 months of the 2015/2016 financial year

Report of the Ordinary General Shareholders’ Meeting - General Meeting approves gross dividend of EUR 2.45 per share

Gimv sells stake in Easyvoyage

Successful investment pathways leading to excellent annual result of EUR 136.0 million - Net asset value up 14% to EUR 42.97 per share - Stable gross dividend of EUR 2.45, representing a dividend yield of 5.8%

Gimv portfolio company Prosonix to be acquired by Circassia Pharmaceuticals

Gimv and the other shareholders are selling their stake in Acertys Groep, a major supplier to hospitals and medical professions

Gimv portfolio company XL Video acquired by PRG

Gimv leads EUR 10 million follow-on financing round at Itineris

Gimv confirms its commitment to infrastructure investor TINC

Gimv invests in United Dutch Breweries, owner of iconic beer brand Oranjeboom

Business update - First 9 months of the 2014/2015 financial year

Gimv portfolio company ActoGenix acquired by Intrexon Corporation